Triple-negative breast cancer (TNBC) represents 10–20% of all breast carcinomas [2] and is characterized by no expression of estrogen receptors (ER) and progesterone receptors (PR), and the lack of overexpression of the HER2 protein. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.